FDA to Hold Forum on Anti-Biofilm Technology
Posted January 24, 2014
Representatives from the U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention, and Environmental Protection Agency are among the experts slated to speak at a Feb. 20 workshop on biofilms and the development of technologies to prevent them.
Biofilms are colonies of microorganisms that form on surfaces, such as those on medical devices, and can be very difficult to remove by central sterile processing personnel. With the increasing use of implanted devices, the FDA says it is crucial to understand more about biofilms, as they can cause healthcare-associated infections. To that end, it is cosponsoring this workshop, scheduled to take place at its White Oak campus in Silver Spring, MD, with the Center for Biofilm Engineering of the Montana State University. The agency is encouraging U.S. government scientists and representatives from academia, the healthcare community, and industry to attend the forum.
Topics slated for discussion at the meeting are the following:
- Research on biofilms and the public health impact.
- Challenges the scientific community, government, and industry face in addressing biofilm contamination.
- Research areas that can address the scientific and clinical challenges surrounding the development of technologies to prevent biofilm formation.
The FDA also has opened a docket seeking comments from interested parties on these topics. The agency will accept comments through March 20, 2014. More information on submitting comments is available in the Jan. 24 Federal Register and may be accessed by clicking here.
HAI Forum Probes Role of Medical Devices and Equipment
Senate Report Cites Delays in Identifying, Addressing Endoscope Contamination Concerns
FDA Panel Acknowledges Safety Risk with Duodenoscope Reprocessing
AAMI Releases 'Must-Have' Guide for Endoscope Reprocessing
CMS Backs Sterilization Terminology Change